Results 261 to 270 of about 32,390 (296)

Is Carvedilol Effective in Preventing and Modulating Concentric Cardiac Remodelling? A Comprehensive Systematic Review and Meta-Analyses. [PDF]

Cardiovasc Ther
Wiyono AV, Ardinal AP.
europepmc   +1 more source

Interplay of serum potassium and kidney function with finerenone in heart failure with mildly reduced or preserved ejection fraction: Findings from FINEARTS‐HF

European Journal of Heart Failure, EarlyView.
CV, cardiovascular, HF, heart failure; K+, serum potassium; eGFR, estimated glomerular filtration rate. Aims Finerenone improved heart failure (HF) outcomes in patients with heart failure and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF). Clinical decision‐making around initiation of mineralocorticoid receptor antagonists often relies on
João Pedro Ferreira, Muthiah Vaduganathan, Brian L. Claggett, Ian Kulac, John W. Ostrominski, Akshay S. Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Bertram Pitt, Katja Rohwedder, Meike Brinker, Patrick Schloemer, John J. V. McMurray, Scott D. Solomon, Faiez Zannad   +17 more
wiley   +1 more source

Metabolic dysregulation in the heart in obesity-associated HFpEF. [PDF]

Front Cardiovasc Med
Valero-Muñoz M, Cooper HL, Li S, Saw EL, Wilson RM, Kusminski CM, Scherer PE, Sam F.   +7 more
europepmc   +1 more source

Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT‐HF registry

European Journal of Heart Failure, EarlyView.
Global patterns of polypharmacy after acute heart failure hospitalization. GDMT, guideline‐directed medical therapy; HF, heart failure. Aims Polypharmacy, defined as the concurrent use of ≥5 medications, is prevalent among older adults with heart failure (HF).
Wan Ting Tay, Tiew‐Hwa Katherine Teng, Wouter Ouwerkerk, John G.F. Cleland, Sean P. Collins, Christiane E. Angermann, Kenneth Dickstein, Ulf Dahlstrom, Anja Schweizer, Achim Obergfell, Kai‐Hang Yiu, Mathieu Ghadanfar, Mahmoud Hassanein, Qing‐Wen Ren, Wen‐Li Gu, Georg Ertl, Sergio V. Perrone, Gerasimos Filippatos, Carolyn S.P. Lam, Jasper Tromp   +19 more
wiley   +1 more source

Mitochondrial dysfunction as a therapeutic nexus in HFpEF: therapeutic target and pharmacological advances. [PDF]

Front Pharmacol
Yue T, Zheng D, He J, Xiong S, Xu J, Hou J.   +5 more
europepmc   +1 more source

Single-cell transcriptomic profiling reveals cell type heterogeneity between HFpEF and HFrEF. [PDF]

Commun Biol
Xiao X, Wu W, Mao Q, Li B, Wang J, Liu S, Zhao H, Long E, Wang J.   +8 more
europepmc   +1 more source

Linking abnormal fat distribution with HFpEF and diastolic dysfunction: a systematic review, meta-analysis, and meta-regression of observational studies

Zhenyue Fu, Yajiao Wang, Yuxin Wang, Shuqing Shi, Yumeng Li, Bingxuan Zhang, Huaqin Wu, Qingqiao Song   +7 more
openalex   +1 more source

European Journal of Heart Failure consensus statement. Heart failure pharmacotherapy for patients with heart failure with reduced ejection fraction and concomitant atrial fibrillation: Review of evidence and call to action

European Journal of Heart Failure, EarlyView.
Heart failure (HF) and atrial fibrillation (AF) are major global health challenges with rising prevalence and significant morbidity, mortality, and healthcare burden. Despite advances in HF management, AF remains a critical comorbidity that worsens outcomes and requires ad hoc treatment strategies, increasing the risk of non‐adherence and side effects.
Mark Luedde, Stefan Agewall, Giuseppe Ambrosio, Antoni Bayes‐Genis, Claudio Borghi, Elisabetta Cerbai, Gheorghe A. Dan, Heinz Drexel, Péter Ferdinandy, Erik Lerkevang Grove, Juan Carlos Kaski, Roland Klingenberg, Joao Morais, William Parker, Mark C. Petrie, Bianca Rocca, Anne Grete Semb, Michele Senni, Christian Sohns, Patrick Sulzgruber, Juan Tamargo, Marco Metra, Michael Böhm, Dobromir Dobrev, Samuel Sossalla   +24 more
wiley   +1 more source

Predicting 30-day and 1-year mortality in heart failure with preserved ejection fraction (HFpEF). [PDF]

PLoS One
Shin I, Bhatt N, Alashi A, Kandala K, Murugiah K.   +4 more
europepmc   +1 more source

Left ventricular transthyretin amyloid load and apical sparing in patients with newly confirmed transthyretin amyloid cardiomyopathy

European Journal of Heart Failure, EarlyView.
In a large cohort of patients with newly diagnosed transthyretin amyloid cardiomyopathy (ATTR‐CM), echocardiographic apical sparing was associated with increased left ventricular amyloid load and atrial remodelling. Quantitative biopsy analysis revealed that Perugini scores often failed to accurately reflect myocardial amyloid burden.
Thomas Krammer, Maria J. Baier, Vanessa Lutz, Anna‐Christina Hübner, Tilman Zschiedrich, David Lukas, Christian Le Phu, Matthias Wolf, Claire Maassen, Michael Wester, Stefan Neef, Christian Schach, Can‐Martin Sag, Katja Evert, Michael Paulus, Christine Meindl, Maria Tafelmeier, Kurt Debl, Lars S. Maier, Stefan Wagner, Christoph Röcken, Julian Mustroph   +21 more
wiley   +1 more source